Ailex Pharmaceuticals Private Limited
About Ailex Pharmaceuticals Private Limited
Data last updated:
Ailex Pharmaceuticals Private Limited is a private limited company based in New Delhi, Delhi, India. It operates in the medicinal chemical and botanical products segment of the chemicals sector. It was incorporated on 10 February 1995 and has been in existence for over 31 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U74899DL1995PTC065287. Its GSTIN is 07AAACA6490M1ZD (Delhi).
The company has an authorised share capital of ₹5 Lakh and a paid-up capital of ₹4.2 Lakh. It is led by directors Mohinder Sud and Anjali Sud.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at B – 404 Som Datt Chambers – 1 5 Bhikaji Cama Place, New Delhi, Delhi, India – 110066.
As per the financials filed for FY 2025, the company reported a revenue of ₹97.94 Lakh, a growth of 19% compared to the previous year. For the same year it recorded a net profit of ₹7.54 Lakh (net margin 7.7%) and EBITDA of ₹11.08 Lakh (EBITDA margin 11.3%). Revenue has grown at a compounded annual rate (CAGR) of 21% over three years and 8% over five years.
Court records list 1 case involving the company, including 1 filed by the company.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Ailex Pharmaceuticals Private Limited's registered office is in New Delhi, Delhi. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressB – 404 Som Datt Chambers – 1 5 Bhikaji Cama Place, New Delhi, Delhi, India – 110066
- IndustryChemicals, Medicinal Chemical & Botanical Products, Pharmaceuticals, Chemical Products
To see the full contact details of Ailex Pharmaceuticals Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Ailex Pharmaceuticals is wholesale and retail trade; repair of motor vehicles and motorcycles. In detail, this covers wholesale and retail trade and repair of motor vehicles and motorcycles.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Wholesale and retail trade; repair of motor vehicles and motorcycles | 45 | Wholesale and retail trade and repair of motor vehicles and motorcycles |
To see the full business activity and turnover split of Ailex Pharmaceuticals Private Limited, buy the company report.
Financials of Ailex Pharmaceuticals Private Limited
FY 2025 filings availableAilex Pharmaceuticals Private Limited reported revenue of ₹97.94 Lakh (up 19% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 8% over five years, including 19% growth in the latest year. EBITDA rose 325% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹11.08 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹7.54 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 11.3% | ||||
| Net Profit Margin | 7.7% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Ailex Pharmaceuticals Private Limited, buy the company report.
Board of directors of Ailex Pharmaceuticals Private Limited
Ailex Pharmaceuticals has 2 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Mohinder Sud Also directs: Solace India Limited | Director | 10 Feb 1995 | 31 Years 8 Months | Current |
| Anjali Sud Also directs: Solace India Limited | Director | 10 Feb 1995 | 31 Years 8 Months | Current |
Auditor
Ailex Pharmaceuticals Private Limited is audited by V.P. BATRA & CO. for the financial year 2017.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| V.P. BATRA & CO. | FY 2017 | 2095N |
Shareholding
The shareholding of Ailex Pharmaceuticals Private Limited is on record for FY 2017, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2017 |
|---|---|
| Promoters | |
| Domestic institutional investors (DII) | |
| Foreign institutional investors (FII) | |
| Public | |
| Others |
To see the full shareholding pattern of Ailex Pharmaceuticals Private Limited, buy the company report.
Legal cases
Ailex Pharmaceuticals Private Limited has 1 court case on record: 1 filed by Ailex Pharmaceuticals. All case is disposed.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 1 | 0 | 0 |
Cases on record (1 of 1)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, New Delhi, Delhi | Civil suit | Filed by the company against Ms Spanco. Ltd. Ors. | Disposed |
To see the full case history of Ailex Pharmaceuticals Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Ailex Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Ailex Pharmaceuticals has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 07AAACA6490M1ZD | Delhi | Active | 07 Nov 2019 |
To see the full GST registrations and return filing status of Ailex Pharmaceuticals Private Limited, buy the company report.
Recent activity
Ailex Pharmaceuticals Private Limited has 4 board changes on record since 1995: 3 appointments and 1 cessation. The latest: Himanshu Sud ceased to be Additional Director on 18 Apr 2019.
Frequently asked questions
Ailex Pharmaceuticals is an active private limited company based in New Delhi, Delhi, India. The company works in medicinal chemical and botanical products, within the chemicals industry. It was incorporated on 10 February 1995 (31+ years old) and is registered under CIN U74899DL1995PTC065287.
Ailex Pharmaceuticals has 2 current directors:
- Mohinder Sud - Director
- Anjali Sud - Director
The latest financial statements of Ailex Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Ailex Pharmaceuticals is 07AAACA6490M1ZD, registered in Delhi.
The CIN (Corporate Identification Number) of Ailex Pharmaceuticals is U74899DL1995PTC065287. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Ailex Pharmaceuticals has 1 court case on record: 1 filed by the company.
Ailex Pharmaceuticals was incorporated on 10 February 1995, making it 31+ years old. It is registered with the Registrar of Companies, Delhi.
Himanshu Sud ceased to be Additional Director on 18 Apr 2019. Himanshu Sud was appointed as Additional Director on 01 Nov 2017. Anjali Sud was appointed as Director on 10 Feb 1995. Ailex Pharmaceuticals has 4 board changes on record in total.
The registered office of Ailex Pharmaceuticals is at B – 404 Som Datt Chambers – 1 5 Bhikaji Cama Place, New Delhi, Delhi, India – 110066.
Ailex Pharmaceuticals operates in the chemicals industry, in the medicinal chemical and botanical products segment.